Non-selective β-blocker (NSBB) therapy is the treatment of choice for primary prophylaxis of cirrhotic patients with high-bleeding risk esophageal varices (HRV). The hemodynamic response to NSBB is assessed by the measurement of the hepatic venous pressure gradient (HVPG). Recently, liver and spleen stiffness measurements (LSM and SSM) were proposed as non-invasive surrogates of HVPG. We aimed to evaluate LSM and SSM changes for assessing hemodynamic response in these patients.
Marasco, G., Dajti, E., Ravaioli, F., Alemanni, L.V., Capuano, F., Gjini, K., et al. (2020). Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients. HEPATOLOGY INTERNATIONAL, 14(5), 850-857 [10.1007/s12072-020-10062-w].
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients
Marasco, Giovanni
;Dajti, Elton;Ravaioli, Federico;Alemanni, Luigina Vanessa;Renzulli, Matteo;Golfieri, Rita;Festi, Davide;
2020
Abstract
Non-selective β-blocker (NSBB) therapy is the treatment of choice for primary prophylaxis of cirrhotic patients with high-bleeding risk esophageal varices (HRV). The hemodynamic response to NSBB is assessed by the measurement of the hepatic venous pressure gradient (HVPG). Recently, liver and spleen stiffness measurements (LSM and SSM) were proposed as non-invasive surrogates of HVPG. We aimed to evaluate LSM and SSM changes for assessing hemodynamic response in these patients.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
